We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
TriLink Announces License Agreement with Lucigen Corporation
News

TriLink Announces License Agreement with Lucigen Corporation

TriLink Announces License Agreement with Lucigen Corporation
News

TriLink Announces License Agreement with Lucigen Corporation

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "TriLink Announces License Agreement with Lucigen Corporation"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

TriLink BioTechnologies, Inc. and Lucigen Corporation have announced that the two companies have signed a licensing agreement for the use of TriLink’s CleanAmp™ dNTPs in Lucigen’s new Taq98™ Hot Start 2X MasterMix.

TriLink’s CleanAmp™ dNTPs are an innovative approach to Hot Start PCR. By simply replacing the standard dNTPs in a PCR assay with CleanAmp™ dNTPs, a Hot Start reaction can be achieved.

This universal approach to high stringency PCR offers a cost effective method to vastly reduce mis-priming, primer dimer formation and other common deleterious off-target effects in PCR.

Lucigen has offered its popular EconoTaq® DNA Polymerase and EconoTaq® PLUS 2X Master Mixes for several years, garnering a reputation for robustness and cost effectiveness.

As part of their mission to simplify genomic research, Lucigen has developed the new Taq98™ Hot Start 2X Master Mix for customers seeking to amplify difficult DNA templates, including targets with >70% GC content. The product is expected to be available for sale in mid-August.

“We believe Taq98™ represents a great combination of performance, ease-of-use, and value for the customer. The addition of the Hot Start feature has significantly increased the market for this product,” stated Jeff Williams, Lucigen President.

“We have found that CleanAmp™ dNTPs improve the performance of a number of thermostable DNA polymerases, allowing for simple conversion of any assay to a Hot Start version. We are pleased to find synergy between TriLink’s CleanAmp™ dNTPs and Lucigen’s amplification product line,” said Dr. Natasha Paul, TriLink Scientific Investigator.

“CleanAmp™ dNTPs are a unique molecular biology tool. As an alternative approach to Hot Start PCR, CleanAmp™ opens new doors for innovation. We are very pleased to be able to work with Lucigen to develop novel products with our combined technologies,” commented TriLink CEO, Dr. Richard Hogrefe.

Advertisement